Assignee
NUCLEIX LTD
IL·8 granted patents·12 pending applications·16 citations·filing 2015–2025
Top patents by PatentIndex Score
20 records- 0191US9476100B1Methods for diagnosing bladder cancerNUCLEIX LTD·Filed 2015·Granted Oct 25, 2016·14 cites·22 claims
- 0285US11434528B2Methods and systems for detecting methylation changes in DNA samplesNUCLEIX LTD·Filed 2020·Granted Sep 6, 2022·2 cites·18 claims
- 0377US12378602B2Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2023·Granted Aug 5, 2025·0 cites·14 claims
- 0477US2025051839A1Methods and systems for detecting methylation changes in dna samplesNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 0577US2025346949A1Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2025·Application pending·0 cites
- 0676US2024287617A1Kits and methods for detecting cancer-related mutationsNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 0775US2026094713A1Deep learning-based methods, devices, and systems for prenatal testingNUCLEIX LTD·Filed 2025·Application pending·0 cites
- 0874US2024209448A1Kits and methods for diagnosing lung cancerNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 0973US12152273B2Methods and systems for detecting methylation changes in DNA samplesNUCLEIX LTD·Filed 2022·Granted Nov 26, 2024·0 cites·28 claims
- 1069US2025210132A1LOW-COVERAGE, GENOME-WIDE IDENTIFICATION OF MINORITY cfDNA CONTRIBUTORSNUCLEIX LTD·Filed 2024·Application pending·0 cites
- 1168US11629375B2Methods and kits for determining the efficiency of plasma separation from whole bloodNUCLEIX LTD·Filed 2019·Granted Apr 18, 2023·0 cites·14 claims
- 1264US11952632B2Kits and methods for detecting cancer-related mutationsNUCLEIX LTD·Filed 2019·Granted Apr 9, 2024·0 cites·20 claims
- 1362US11866786B2Kits and methods for diagnosing lung cancerNUCLEIX LTD·Filed 2019·Granted Jan 9, 2024·0 cites·9 claims
- 1462US2025092461A1Personalized cancer management and monitoring based on dna methylation changes in cell-free dnaNUCLEIX LTD·Filed 2023·Application pending·0 cites
- 1560US2025011858A1Whole genome cpg analysisNUCLEIX LTD·Filed 2022·Application pending·0 cites
- 1659US2025327115A1Reaction buffer compositions and methods for dna amplification and sequencingNUCLEIX LTD·Filed 2023·Application pending·0 cites
- 1756US2024026453A1Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencingNUCLEIX LTD·Filed 2021·Application pending·0 cites
- 1856US2024093302A1Non-invasive cancer detection based on dna methylation changesNUCLEIX LTD·Filed 2022·Application pending·0 cites
- 1950US12462935B2Deep learning-based methods, devices, and systems for prenatal testingNUCLEIX LTD·Filed 2019·Granted Nov 4, 2025·0 cites·16 claims
- 2050US2025320563A1Sample preparation for cell-free dna analysisNUCLEIX LTD·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →